APA (7th ed.) Citation

Tetsuro Marunouchi, Kyo Fujita, Kirara Takahashi, Shunsuke Namiki, Lina Kyo, Manami Uchida, . . . Kouichi Tanonaka. (2023). Simvastatin attenuates the c-Raf/Erk and calcineurin-NFATc2 pathways via inhibition of Hsp90 activity during the development of heart failure. Elsevier.

Chicago Style (17th ed.) Citation

Tetsuro Marunouchi, Kyo Fujita, Kirara Takahashi, Shunsuke Namiki, Lina Kyo, Manami Uchida, Emi Yano, and Kouichi Tanonaka. Simvastatin Attenuates the C-Raf/Erk and Calcineurin-NFATc2 Pathways via Inhibition of Hsp90 Activity During the Development of Heart Failure. Elsevier, 2023.

MLA (9th ed.) Citation

Tetsuro Marunouchi, et al. Simvastatin Attenuates the C-Raf/Erk and Calcineurin-NFATc2 Pathways via Inhibition of Hsp90 Activity During the Development of Heart Failure. Elsevier, 2023.